Title : Clinical development of nintedanib for advanced non-small-cell lung cancer.

Pub. Date : 2015

PMID : 26622180






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Nintedanib is a small-molecule tyrosine kinase inhibitor that targets receptors for vascular endothelial growth factor, platelet-derived growth factor, and fibroblast growth factor as well as RET (rearranged during transfection) and Flt3. nintedanib ret proto-oncogene Homo sapiens
2 Nintedanib is a small-molecule tyrosine kinase inhibitor that targets receptors for vascular endothelial growth factor, platelet-derived growth factor, and fibroblast growth factor as well as RET (rearranged during transfection) and Flt3. nintedanib ret proto-oncogene Homo sapiens